NCT03721406View on ClinicalTrials.gov

Pharmacokinetic of Thoracic Paravertebral Ropivacaine

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

October 25, 2021

Study Completion Date

November 25, 2021

Conditions
Open Thoracotomy
Interventions
DRUG

Ropivacaine

ropivacaine administerd via thoracic paraveretebral catheter

Trial Locations (2)

12462

2nd Department of Anesthesiology, Attikon University Hospital, Athens

13231

Paraskevi K Matsota, Athens

All Listed Sponsors
lead

Attikon Hospital

OTHER

NCT03721406 - Pharmacokinetic of Thoracic Paravertebral Ropivacaine | Biotech Hunter | Biotech Hunter